20 May 2013
Keywords: fast-track, approval, gw, lotronex, update, glaxo, wellcome
Article | 31 August 1999
Glaxo Wellcome says that the US Food and Drug Administration is tofast-track its drug Lotronex (alosetron). Marking the first filing ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.